EzriCare Artificial Tears and Delsam Pharma’s Artificial Tears are a popular over-the-counter option for dry eyes, but they can cause infections in some people. As a result of the CDC’s recommendation, the manufacturer of the popular Artificial Tears has taken the eye drops off the market.
Pogust Goodhead is filing a lawsuit to help those who have been affected by the product seek compensation.
The problem with EzriCare’s Artificial Tears
Intended to lubricate and relieve dry eye symptoms, the eye drops are now being linked to various infections because they do not contain an anti-microbial agent.
The CDC has recommended immediate discontinuation of the use of EzriCare and Delsam Pharma’s Artificial Tears, an OTC drop for dry eye, after linking it with various infections and, in one case, death. They said: “patients should immediately discontinue the use of EzriCare Artificial Tears until the epidemiological investigation and laboratory analyses are complete.”
The contamination is believed to have originated in the manufacturing plant as a result of deficiencies in the process control standards. This can result in contamination of the product with microorganisms that could be harmful to patients.
Who was affected by the EzriCare Artificial Tears recall?
From May 17, 2022, to January 19, 2023, CDC, in partnership with state and local health departments, identified 56 isolates from 50 case-patients in 11 different states. This was a collaborative effort involving state and local health departments that sent collection plates for clinical specimens and biospecimena.
In a statement from January 20, 2023, the CDC reported that one person had died and at least three others were left with permanent vision loss. A majority of those affected reported using preservative-free Artificial Tears before becoming ill, the CDC reported in a statement dated Jan. 20.
While the infections have not been definitively traced to the eyedrops, the CDC is taking this precautionary measure in order to ensure the safety of all patients.
If you or a loved one has suffered after using EzriCare Artificial Tears, or Delsam Pharma’s Artificial Tears, you may be owed compensation. Our team, including Partner Mike Daly, can assess your claim today.
EzriCare in the news
Bloomberg and The Wall Street Journal have both reported on the EzriCare artificial tears scandal, among other prestigious news outlets. You can read more on these stories here:
